- Home
- NXPI vs ELV Comparison
NXPI vs ELV Comparison
Compare NXPI & ELV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPI
- ELV
- Stock Information
- Founded
- NXPI 2006
- ELV 1944
- Country
- NXPI Netherlands
- ELV United States
- Employees
- NXPI N/A
- ELV N/A
- Industry
- NXPI Semiconductors
- ELV Medical Specialities
- Sector
- NXPI Technology
- ELV Health Care
- Exchange
- NXPI Nasdaq
- ELV Nasdaq
- Market Cap
- NXPI 59.2B
- ELV 61.8B
- IPO Year
- NXPI 2010
- ELV N/A
- Fundamental
- Price
- NXPI $234.30
- ELV $318.67
- Analyst Decision
- NXPI Strong Buy
- ELV Buy
- Analyst Count
- NXPI 20
- ELV 15
- Target Price
- NXPI $250.30
- ELV $411.86
- AVG Volume (30 Days)
- NXPI 2.5M
- ELV 2.1M
- Earning Date
- NXPI 07-21-2025
- ELV 10-16-2025
- Dividend Yield
- NXPI 1.73%
- ELV 2.15%
- EPS Growth
- NXPI N/A
- ELV N/A
- EPS
- NXPI 8.39
- ELV 23.39
- Revenue
- NXPI $12,122,000,000.00
- ELV $189,254,000,000.00
- Revenue This Year
- NXPI N/A
- ELV $12.43
- Revenue Next Year
- NXPI $9.59
- ELV $5.55
- P/E Ratio
- NXPI $28.48
- ELV $13.63
- Revenue Growth
- NXPI N/A
- ELV 10.21
- 52 Week Low
- NXPI $148.09
- ELV $273.71
- 52 Week High
- NXPI $257.61
- ELV $567.26
- Technical
- Relative Strength Index (RSI)
- NXPI 65.69
- ELV 58.76
- Support Level
- NXPI $234.70
- ELV $305.34
- Resistance Level
- NXPI $239.50
- ELV $319.22
- Average True Range (ATR)
- NXPI 7.28
- ELV 6.48
- MACD
- NXPI 1.88
- ELV 3.42
- Stochastic Oscillator
- NXPI 98.87
- ELV 95.29
About NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About ELV Elevance Health Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.